Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 9/20 | 0.62 |
| ▸ | PRKCG | P05129 | 2/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.57 |
| ▸ | CETP | P11597 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3799469 | 0.93 | NT5E (0.61) | NT5EPRKCGPRKCDCETP | |
| SCHEMBL6119298 | 0.87 | SLC10A1 (0.65) | NT5EPRKCGPRKCD | |
| SCHEMBL6119253 | 0.84 | CA9 (0.67) | NT5EPRKCG | |
| SCHEMBL3797106 | 0.83 | GPBAR1 (0.70) | NT5EPTPN1USP2LMNAHIF1A | |
| SCHEMBL6112929 | 0.80 | NT5E (0.74) | NT5EPRKCGPRKCDCETPPTPN1 | |
| SCHEMBL6112780 | 0.79 | PTPN1 (0.62) | NT5EPTPN1USP2LMNAHIF1A | |
| SCHEMBL6119254 | 0.79 | NT5E (0.64) | NT5EPRKCGPRKCDCETPPTPN1 | |
| SCHEMBL3787604 | 0.79 | GPBAR1 (0.48) | NT5EPTPN1USP2LMNAHIF1A | |
| SCHEMBL10214539 | 0.78 | NT5E (0.71) | NT5EPRKCGPRKCDCETPPTPN1 | |
| SCHEMBL14163543 | 0.77 | NT5E (0.70) | NT5EPRKCGPRKCDCETPPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969395-B2 | Triterpenoid derivatives useful as antiproliferative agents | UNIVERSIDADE DE COIMBRA (PT) | 2015-03-03 | — | — | US | disclosed |
| US-20120129901-A1 | TRITERPENOID DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | UNIVERSIDADE DE COIMBRA (PT) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129901-A1 | TRITERPENOID DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | ALPI, LSS, CYP46A1 | NT5E 4541/4885PRKCG 2366/4885PRKCD 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.